HHLR ADVISORS, LTD. - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 221 filers reported holding BRIDGEBIO PHARMA INC in Q1 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.

Quarter-by-quarter ownership
HHLR ADVISORS, LTD. ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$73,381,118
+42.5%
2,782,750
-7.0%
1.64%
+49.5%
Q2 2023$51,487,288
-21.9%
2,993,447
-24.8%
1.10%
-6.3%
Q1 2023$65,962,038
+66.9%
3,978,410
-23.3%
1.17%
+40.3%
Q4 2022$39,526,655
-25.8%
5,187,225
-3.3%
0.83%
-40.5%
Q3 2022$53,298,000
+9.5%
5,362,0140.0%1.40%
+34.2%
Q2 2022$48,687,000
-10.5%
5,362,0140.0%1.04%
-8.1%
Q1 2022$54,424,000
-39.1%
5,362,0140.0%1.14%
-17.8%
Q4 2021$89,438,000
-64.4%
5,362,0140.0%1.38%
-58.0%
Q3 2021$251,318,000
-23.1%
5,362,0140.0%3.29%
-2.3%
Q2 2021$326,868,000
-1.0%
5,362,0140.0%3.36%
+3.1%
Q1 2021$330,300,000
-1.4%
5,362,014
+13.8%
3.26%
+22.5%
Q4 2020$335,042,000
+89.5%
4,711,6040.0%2.66%
+99.0%
Q3 2020$176,779,000
+15.1%
4,711,6040.0%1.34%
-4.6%
Q2 2020$153,645,000
+12.4%
4,711,6040.0%1.40%
-23.7%
Q1 2020$136,637,000
-11.2%
4,711,604
+7.4%
1.84%
-3.9%
Q4 2019$153,824,000
+63.3%
4,388,6900.0%1.92%
+48.0%
Q3 2019$94,225,000
+48.5%
4,388,690
+86.5%
1.30%
-8.7%
Q2 2019$63,458,0002,352,9001.42%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q1 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$55,099,00039.31%
M28 Capital Management LP 466,200$4,233,0004.74%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$282,034,0003.75%
Octagon Capital Advisors LP 933,743$8,478,0002.26%
VIKING GLOBAL INVESTORS LP 26,620,991$241,719,0001.11%
HHLR ADVISORS, LTD. 5,362,014$48,687,0001.04%
Cormorant Asset Management, LP 1,469,179$13,340,0001.01%
Knott David M Jr 213,206$1,936,0000.81%
Fernwood Investment Management, LLC 183,900$1,670,0000.72%
HighVista Strategies LLC 105,942$962,0000.58%
View complete list of BRIDGEBIO PHARMA INC shareholders